Increased susceptibility to tumor necrosis factor-α in butyric acid-induced apoptosis is caused by downregulation of cFLIP expression in Jurkat T cells

Microbiology and Immunology

Volumn 52, Issue 3, 2008, Pages 188-196

  Seto, Shintaro ^a   Kurita Ochiai, Tomoko ^b   Ochiai, Kuniyasu ^b,c  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Butyric acid; Cellular FADD like ICE inhibitory protein; Tumor necrosis factor alpha

Indexed keywords

BUTYRIC ACID; CASPASE; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL VIABILITY; CHEMICAL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOSYNTHESIS; DOWN REGULATION; GENE EXPRESSION PROFILING; IMMUNOLOGY;

NEGIBACTERIA;

APOPTOSIS; BUTYRIC ACID; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; JURKAT CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51449087401     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00023.x     Document Type: Article

References (41)

1. Soder P.O., Jin L.J., Soder B. (1993) DNA probe detection of periodontopathogens in advanced periodontitis. Scand J Dent Res 101: 363-70.
2. Kurita-Ochiai T., Fukushima K., Ochiai K. (1997) Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells. Infect Immun 65: 35-41.
3. Kurita-Ochiai T., Fukushima K., Ochiai K. (1995) Volatile fatty acids, metabolic by-products of periodontopathic bacteria, inhibit lymphocyte proliferation and cytokine production. J Dent Res 74: 1367-73.
4. Kurita-Ochiai T., Ochiai K., Fukushima K. (1998) Volatile fatty acid, metabolic by-product of periodontopathic bacteria, induces apoptosis inWEHI 231 and RAJI B lymphoma cells and splenic B cells. Infect Immun 66: 2587-94.
5. Kurita-Ochiai T., Amano S., Fukushima K., Ochiai K. (2003) Cellular events involved in butyric acid-induced T cell apoptosis. J Immunol 171: 3576-84.
6. Kurita-Ochiai T., Ochiai K., Fukushima K. (2000) Butyric-acid-induced apoptosis in murine thymocytes and splenic T- and B-cells occurs in the absence of p53. J Dent Res 79: 1948-54.
7. Kurita-Ochiai T., Ochiai K., Fukushima K. (2001) Butyric acid-induced T-cell apoptosis is mediated by caspase-8 and -9 activation in a Fas-independent manner. Clin Diagn Lab Immunol 8: 325-32.
8. Kurita-Ochiai T., Fukushima K., Ochiai K. (1999) Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells. Infect Immun 67: 22-9.
9. Page R.C. (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26: 230-42.
10. Graves D.T., Cochran D. (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74: 391-401.
11. Stashenko P., Jandinski J.J., Fujiyoshi P., Rynar J., Socransky S.S. (1991) Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 62: 504-9.
12. Okada H., Kida T., Yamagami H. (1983) Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis. Infect Immun 41: 365-74.
13. Kurita-Ochiai T., Ochiai K., Suzuki N., Otsuka K., Fukushima K. (2002) Human gingival fibroblasts rescue butyric acid-induced T-cell apoptosis. Infect Immun 70: 2361-7.
14. Kurita-Ochiai T., Seto S., Ochiai K. (2004) Role of cell-cell communication in inhibiting butyric acid-induced T-cell apoptosis. Infect Immun 72: 5947-54.
15. Seymour G.J., Powell R.N., DaviesW.I. (1979) Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory periodontal disease: an hypothesis. J Clin Periodontol 6: 267-77.
16. Kurita-Ochiai T., Seto S., Suzuki N., Yamamoto M., Otsuka K., Ochiai K. (2008) Butyric acid induces apoptosis in inflamed fibroblast. J Dent Res 87: 52-5.
17. Inohara N., Koseki T., Hu Y., Chen S., Nunez G. (1997) CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc Natl Acad Sci USA 94: 10717-22.
18. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer, J.L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L.E., Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-5.
19. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O'Rourke K., Kischkel F.C., Hellbardt S., Krammer, P.H., Peter, M.E., Dixit, V.M. (1996) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem271: 4961-5.
20. Margolis H.C., Duckworth J.H., Moreno E.C. (1988) Composition and buffer capacity of pooled starved plaque fluid from caries-free and caries-susceptible individuals. J Dent Res 67: 1476-82.
21. Chen M.,Wang J. (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7: 313-9.
22. TewariM., Quan L.T.,O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R, Poirier, G.G., Salvesen, G.S., Dixit, V.M. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-9.
23. Vidali G., Boffa L.C., Bradbury E.M., Allfrey V.G. (1978) Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 75: 2239-43.
24. Joseph J., Mudduluru G., Antony S., Vashistha S., Ajitkumar P., Somasundaram K. (2004) Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 23: 6304-15.
25. Kataoka T. (2005) The caspase-8 modulator c-FLIP. Crit Rev Immunol 25: 31-58.
26. Wajant H., Johannes F.J., Haas E., Siemienski K., Schwenzer R., Schubert G.,Weiss, T., Grell, M., Scheurich, P. (1998) Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr Biol 8: 113-16.
27. Debatin K.M., Krammer P.H. (2004) Death receptors in chemotherapy and cancer. Oncogene 23: 2950-66.
28. Birkedal-Hansen H. (1993) Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 28: 500-10.
29. Bernhard D., Skvortsov S., Tinhofer I., Hubl H., Greil R., Csordas A., R. Kofler. (2001) Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. Cell Death Differ 8: 1014-21.
30. Imai T., Adachi S., Nishijo K., Ohgushi M., Okada M., Yasumi T., Watanabe, K., Nishikomori, R., Nakayama, T., Yonehara, S., Toguchida, J., Nakahata, T. (2003) FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Oncogene 22: 9231-42.
31. Ruefli A.A., Ausserlechner M.J., Bernhard D., Sutton V.R., Tainton K.M., Kofler R., Smyth, M.J., Johnstone, R.W. (2001) The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci USA 98: 10833-8.
32. Aron J.L., Parthun M.R., Marcucci G., Kitada S., Mone A.P., Davis M.E., Shen, T., Murphy, T.,Wickham, J., Kanakry, C., Lucas, D.M., Reed, J.C., Grever, M.R., Byrd, J.C. (2003) Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 102: 652-8.
33. Guo F., Sigua C., Tao J., Bali P., George P., Li Y.,Wittmann, S., Moscinski, L., Atadja, P., Bhalla, K. (2004) Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Cancer Res 64: 2580-9.
34. Nakata S., Yoshida T., Horinaka M., Shiraishi T.,Wakada M., Sakai T. (2004) Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Oncogene 23: 6261-71.
35. Watanabe K., Okamoto K., Yonehara S. (2005) Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. Cell Death Differ 12: 10-18.
36. Thorburn A. (2004) Death receptor-induced cell killing. Cell Signal 16: 139-44.
37. Budihardjo I., Oliver H., Lutter M., Luo X.,Wang X. (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-90.
38. Micheau O., Tschopp J. (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-90.
39. Nakajima, A., Kojima Y., Nakayama M., Yagita H., Okumura K., Nakano H.. (2008). Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells. Oncogene 27: 76-84.
40. Rippo M.R., Moretti S., Vescovi S., Tomasetti M., Orecchia S., Amici G., Catalano, A., Procopio, A. (2004) FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Oncogene 23: 7753-60.
41. Sharp D.A., Lawrence D.A., Ashkenazi A. (2005) Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem280: 19401-9.